AI assistant
GlaxoSmithKline PLC — Regulatory Filings 2012
Nov 8, 2012
5262_ffr_2012-11-08_adbe61e6-17f6-4479-9826-4e058369b04b.zip
Regulatory Filings
Open in viewerOpens in your device viewer
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For period ending November 2012
GlaxoSmithKline plc
(Name of registrant)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F
Form 20-F x Form 40-F
--
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
Yes No x
--
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris .
Date: 8 November 2012
| Name of applicant : — Name of scheme: | GlaxoSmithKline plc — GlaxoSmithKline Share Option Plan - Ordinary Shares | |||
|---|---|---|---|---|
| Period of return: | From: | 1 May 2012 | To: | 31 October 2012 |
| Balance of unallotted securities under scheme(s) from previous return: | 14,090,687 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 4,373,486 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 9,717,201 |
| Name of contact: | Victoria Whyte |
|---|---|
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris .
Date: 8 November 2012
| Name of applicant : — Name of scheme: | GlaxoSmithKline plc — GlaxoSmithKline Share Option Plan - ADS | |||
|---|---|---|---|---|
| Period of return: | From: | 1 May 2012 | To: | 31 October 2012 |
| Balance of unallotted securities under scheme(s) from previous return: | 5,537,568 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 10,000,000 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 7,175,490 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 8,362,078 |
| Name of contact: | Victoria Whyte |
|---|---|
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris .
Date: 8 November 2012
| Name of applicant : — Name of scheme: | GlaxoSmithKline plc — Glaxo Wellcome UK Share Option Scheme | |||
|---|---|---|---|---|
| Period of return: | From: | 1 May 2012 | To: | 31 October 2012 |
| Balance of unallotted securities under scheme(s) from previous return: | 5,119,750 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 5,119,750 |
| Name of contact: | Victoria Whyte |
|---|---|
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris .
Date: 8 November 2012
| Name of applicant : — Name of scheme: | GlaxoSmithKline plc — Glaxo Wellcome International Share Option Scheme | |||
|---|---|---|---|---|
| Period of return: | From: | 1 May 2012 | To: | 31 October 2012 |
| Balance of unallotted securities under scheme(s) from previous return: | 13,267,156 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 13,267,156 |
| Name of contact: | Victoria Whyte |
|---|---|
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris .
Date: 8 November 2012
| Name of applicant : — Name of scheme: | GlaxoSmithKline plc — Glaxo Wellcome 1999 Share Option Plan | |||
|---|---|---|---|---|
| Period of return: | From: | 1 May 2012 | To: | 31 October 2012 |
| Balance of unallotted securities under scheme(s) from previous return: | 1,040,000 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 1,040,000 |
| Name of contact: | Victoria Whyte |
|---|---|
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris .
Date: 8 November 2012
| Name of applicant : — Name of scheme: | GlaxoSmithKline plc — SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares | |||
|---|---|---|---|---|
| Period of return: | From: | 1 May 2012 | To: | 31 October 2012 |
| Balance of unallotted securities under scheme(s) from previous return: | 163,606 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 163,606 |
| Name of contact: | Victoria Whyte |
|---|---|
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris .
Date: 8 November 2012
| Name of applicant : — Name of scheme: | GlaxoSmithKline plc — SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS | |||
|---|---|---|---|---|
| Period of return: | From: | 1 May 2012 | To: | 31 October 2012 |
| Balance of unallotted securities under scheme(s) from previous return: | 275,420 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 275,420 |
| Name of contact: | Victoria Whyte |
|---|---|
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris .
Date: 8 November 2012
| Name of applicant : — Name of scheme: | GlaxoSmithKline plc — SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary | |||
|---|---|---|---|---|
| Period of return: | From: | 1 May 2012 | To: | 31 October 2012 |
| Balance of unallotted securities under scheme(s) from previous return: | 100,000 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 100,000 |
| Name of contact: | Victoria Whyte |
|---|---|
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an Ris .
Date: 8 November 2012
| Name of applicant : — Name of scheme: | GlaxoSmithKline plc — GlaxoSmithKline Savings Related Share Option Scheme | |||
|---|---|---|---|---|
| Period of return: | From: | 1 May 2012 | To: | 31 October 2012 |
| Balance of unallotted securities under scheme(s) from previous return: | 4,005,708 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 115,727 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 3,889,981 |
| Name of contact: | Victoria Whyte |
|---|---|
| Telephone number of contact: | 020 8047 5000 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
GlaxoSmithKline plc
(Registrant)
Date: November 08, 2012
By: VICTORIA WHYTE
Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc